🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
60.36
-0.61 (-1.00%)
Nov 17, 2026, 4:00 PM EST - Market closed

PTC Therapeutics Revenue

PTC Therapeutics had revenue of $357.81M in the quarter ending September 30, 2026, with 69.57% growth. This brings the company's total for the last twelve months to $1.16B, down -35.05% year-over-year. In the year 2025, PTC Therapeutics had annual revenue of $1.73B with 114.51% growth. That makes PTC Therapeutics the 7,019th largest company in the world by revenue and 1,696th in the United States.

Revenue (ttm)
$1.16B
Revenue Growth
-35.05%
P/S Ratio
4.36
Revenue / Employee
$1,166,048
Employees
991
Market Cap
5.04B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Translarna 321.07M 39.8%
  • Emflaza 207.22M 25.7%
  • Royalty 203.86M 25.3%
  • All Other Products 36.95M 4.6%
  • Translarna France 18.81M 2.3%
  • Upstaza/Kebilidi 16.91M 2.1%
  • Manufacturing 1.66M 0.2%
  • Collaboration and License 304.00K 0.0%

By Geography

Chart
  • United States (US) 413.04M 51.2%
  • Non-US 393.74M 48.8%
Fiscal year ended Dec 31, 2024 See the full PTC Therapeutics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.73B923.88M114.51%
Dec 31, 2024806.78M-131.04M-13.97%
Dec 31, 2023937.82M239.02M34.20%
Dec 31, 2022698.80M160.21M29.75%
Dec 31, 2021538.59M157.83M41.45%
Dec 31, 2020380.77M73.79M24.04%
Dec 31, 2019306.98M42.25M15.96%
Dec 31, 2018264.73M70.34M36.19%
Dec 31, 2017194.39M111.69M135.04%
Dec 31, 201682.71M45.94M124.95%
Dec 31, 201536.77M11.52M45.64%
Dec 31, 201425.25M-9.45M-27.24%
Dec 31, 201334.70M750.00K2.21%
Dec 31, 201233.95M-71.47M-67.80%
Dec 31, 2011105.41M100.45M2,022.34%
Dec 31, 20054.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.